Stockreport

Retrophin Reports Second Quarter 2018 Financial Results and Announces CEO Transition Plan

RETROPHIN INC  (RTRX) 
Last retrophin inc earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.retrophin.com/investor-relations
PDF Patients continue to enroll in Phase 3 FORT Study of fosmetpantotenate in PKAN and Phase 3 DUPLEX Study of sparsentan in FSGS Phase 2 proof-of-concept study of CNSA-001 [Read more]